|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
03737 ZHONGZHIPHARM
Nominal 
0.670 -0.020 (-2.899%) | 2025/06 - Interim RMB(K¥) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | |
| Net Cash from / (used in) Operating Activities | -- | 181,480 | 101,503 | 284,574 | 178,379 |
| Net Cash from / (used in) Investing Activities | -- | (120,064) | (202,758) | 13,380 | (135,980) |
| Net Cash from / (used in) Financing Activities | -- | (58,735) | (154,618) | (68,144) | (40,831) |
| Increase / (Decrease) in Cash & Cash Equivalents | -- | 2,681 | (255,873) | 229,810 | 1,568 |
| Cash & Cash Equivalents at beginning of period | -- | 124,368 | 381,010 | 153,381 | 151,032 |
| Effect of Foreign Exchange Rate Changes | -- | 54 | (769) | (2,181) | 781 |
| Others | -- | 0 | 0 | 0 | 0 |
| Cash & Cash Equivalents at end of period | -- | 127,103 | 124,368 | 381,010 | 153,381 |
| Remarks: | Real time quote last updated: 11/09/2025 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 8,783 |
| %Change | -89.474% |
| EPS / (LPS) | RMB 0.010 |
| NBV Per Share (¥) | RMB 1.257 |